Physician profile
Neil E Richard
NPI 1801865670
$10,654.51
in general payments reported to CMS, 2019-2025
57 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,455 · 2020: $1,494 · 2021: $2,454 · 2022: $2,309 · 2023: $1,394 · 2024: $310 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,942.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,117.38 | 2019-2024 | Jardiance, Spiriva Respimat |
| Abbvie INC. | $1,012.58 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $959.56 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $862.24 | 2019-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $763.08 | 2019-2023 | Wegovy |
| Pfizer INC. | $610.84 | 2019-2024 | |
| Lilly USA, LLC | $557.51 | 2019-2025 | Mounjaro, Trulicity, Jardiance |
| Glaxosmithkline, LLC. | $504.54 | 2019-2023 | Trelegy Ellipta |
| Astellas Pharma US INC | $400.42 | 2019-2021 | |
| Abbott Laboratories | $321.01 | 2019-2023 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $313.82 | 2019-2024 | Gardasil 9, M-M-R II, Vaqta |
| Bayer Healthcare Pharmaceuticals INC. | $297.53 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $279.31 | 2019-2025 | Xifaxan, Trulance, Cycloset |
| Novartis Pharmaceuticals Corporation | $267.65 | 2019-2022 | |
| Amarin Pharma, INC. | $257.30 | 2019-2023 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Richard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.